EVC2 p.Leu18Phe

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_147127.5(EVC2):​c.52C>T​(p.Leu18Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.133 in 1,505,760 control chromosomes in the GnomAD database, including 15,591 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. L18L) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.18 ( 2994 hom., cov: 32)
Exomes 𝑓: 0.13 ( 12597 hom. )

Consequence

EVC2
NM_147127.5 missense

Scores

3
15

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: -0.0250

Publications

10 publications found
Variant links:
Genes affected
EVC2 (HGNC:19747): (EvC ciliary complex subunit 2) This gene encodes a protein that functions in bone formation and skeletal development. Mutations in this gene, as well as in a neighboring gene that lies in a head-to-head configuration, cause Ellis-van Creveld syndrome, an autosomal recessive skeletal dysplasia that is also known as chondroectodermal dysplasia. Mutations in this gene also cause acrofacial dysostosis Weyers type, also referred to as Curry-Hall syndrome, a disease that combines limb and facial abnormalities. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2009]
EVC2 Gene-Disease associations (from GenCC):
  • acrofacial dysostosis, Weyers type
    Inheritance: AD, AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet, G2P
  • Ellis-van Creveld syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics, Myriad Women's Health, Laboratory for Molecular Medicine

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_147127.5, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.004922539).
BP6
Variant 4-5708462-G-A is Benign according to our data. Variant chr4-5708462-G-A is described in ClinVar as Benign. ClinVar VariationId is 262618.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.297 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_147127.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
EVC2
NM_147127.5
MANE Select
c.52C>Tp.Leu18Phe
missense
Exon 1 of 22NP_667338.3
EVC2
NM_001166136.2
c.-13+367C>T
intron
N/ANP_001159608.1Q86UK5-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
EVC2
ENST00000344408.10
TSL:1 MANE Select
c.52C>Tp.Leu18Phe
missense
Exon 1 of 22ENSP00000342144.5Q86UK5-1
EVC2
ENST00000310917.6
TSL:1
c.-13+367C>T
intron
N/AENSP00000311683.2Q86UK5-2
EVC2
ENST00000475313.5
TSL:1
n.-13+367C>T
intron
N/AENSP00000431981.1A0A0C4DGE7

Frequencies

GnomAD3 genomes
AF:
0.178
AC:
26979
AN:
151866
Hom.:
2982
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.302
Gnomad AMI
AF:
0.296
Gnomad AMR
AF:
0.189
Gnomad ASJ
AF:
0.104
Gnomad EAS
AF:
0.177
Gnomad SAS
AF:
0.191
Gnomad FIN
AF:
0.113
Gnomad MID
AF:
0.102
Gnomad NFE
AF:
0.112
Gnomad OTH
AF:
0.160
GnomAD2 exomes
AF:
0.152
AC:
15220
AN:
100284
AF XY:
0.149
show subpopulations
Gnomad AFR exome
AF:
0.291
Gnomad AMR exome
AF:
0.210
Gnomad ASJ exome
AF:
0.0984
Gnomad EAS exome
AF:
0.145
Gnomad FIN exome
AF:
0.120
Gnomad NFE exome
AF:
0.111
Gnomad OTH exome
AF:
0.129
GnomAD4 exome
AF:
0.128
AC:
173268
AN:
1353784
Hom.:
12597
Cov.:
31
AF XY:
0.129
AC XY:
85908
AN XY:
667562
show subpopulations
African (AFR)
AF:
0.311
AC:
8587
AN:
27608
American (AMR)
AF:
0.208
AC:
6864
AN:
33062
Ashkenazi Jewish (ASJ)
AF:
0.103
AC:
2487
AN:
24084
East Asian (EAS)
AF:
0.244
AC:
7790
AN:
31934
South Asian (SAS)
AF:
0.187
AC:
14228
AN:
76252
European-Finnish (FIN)
AF:
0.122
AC:
4065
AN:
33296
Middle Eastern (MID)
AF:
0.113
AC:
455
AN:
4014
European-Non Finnish (NFE)
AF:
0.114
AC:
121234
AN:
1067036
Other (OTH)
AF:
0.134
AC:
7558
AN:
56498
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
8176
16352
24527
32703
40879
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4694
9388
14082
18776
23470
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.178
AC:
27045
AN:
151976
Hom.:
2994
Cov.:
32
AF XY:
0.179
AC XY:
13287
AN XY:
74282
show subpopulations
African (AFR)
AF:
0.302
AC:
12526
AN:
41490
American (AMR)
AF:
0.189
AC:
2894
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.104
AC:
359
AN:
3460
East Asian (EAS)
AF:
0.177
AC:
900
AN:
5086
South Asian (SAS)
AF:
0.192
AC:
925
AN:
4824
European-Finnish (FIN)
AF:
0.113
AC:
1193
AN:
10600
Middle Eastern (MID)
AF:
0.113
AC:
33
AN:
292
European-Non Finnish (NFE)
AF:
0.112
AC:
7598
AN:
67926
Other (OTH)
AF:
0.165
AC:
349
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1070
2139
3209
4278
5348
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
286
572
858
1144
1430
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0792
Hom.:
153
Bravo
AF:
0.187
Asia WGS
AF:
0.237
AC:
824
AN:
3470

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
not specified (3)
-
-
2
Ellis-van Creveld syndrome (2)
-
-
2
not provided (2)
-
-
1
Curry-Hall syndrome (1)
-
-
1
Ellis-van Creveld syndrome;C0457013:Curry-Hall syndrome (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.54
T
BayesDel_noAF
Benign
-0.40
CADD
Benign
15
DANN
Uncertain
0.99
DEOGEN2
Benign
0.046
T
Eigen
Benign
-0.86
Eigen_PC
Benign
-1.0
FATHMM_MKL
Benign
0.026
N
LIST_S2
Benign
0.51
T
MetaRNN
Benign
0.0049
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.69
N
PhyloP100
-0.025
PrimateAI
Uncertain
0.78
T
PROVEAN
Benign
-0.85
N
REVEL
Benign
0.24
Sift
Benign
0.075
T
Sift4G
Uncertain
0.036
D
PromoterAI
-0.091
Neutral
Varity_R
0.063
gMVP
0.12
Mutation Taster
=92/8
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs6820907;
hg19: chr4-5710189;
COSMIC: COSV53828801;
COSMIC: COSV53828801;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.